Infectious Diseases
Tedizolid PSK
Registration certificate:
INN:
Tedizolid
Release form:
Lyophilisate for concentrate for solution for infusion
Therapeutic Area:
Infectious Diseases
Pharmacotherapeutic Group:
Antibacterial agents for systemic use, Other antibacterial agents
Conditions for dispensing:
On prescription
Packaging:

Indications for Use:

Treatment of complicated skin and soft tissue infections caused by sensitive microorganisms:

  • Staphylococcus aureus (including methicillin-resistant [MRSA] and methicillin-sensitive [MSSA] strains),

  • Streptococcus pyogenes (group A beta-hemolytic streptococci),

  • Streptococcus agalactiae (group B beta-hemolytic streptococci),

  • Streptococcus anginosus group, including Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus,

  • Enterococcus faecalis.

Current official guidelines for the use of antibacterial agents must be taken into account.

This product is included in the Essential Drug List (EDL).

Regulatory Status: Rx only.

THERE ARE CONTRAINDICATIONS. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of Tedizolid PSK (INN: tedizolid), lyophilisate, 200 mg leaflet, pleasevisit this website: https://grls.rosminzdrav.ru/Default.aspx.

 

Quality control
at all stages of production